Return to homepagePandemic Pact

SARS-MAB - Generation of murine, monoclonal antibodies against SARS-CoV-2

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:0 publications

Grant number: 01KI2046

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $54,000

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Principal Investigator

    Dr. Frank Sellrie

  • Research Location

    Germany

  • Lead Research Institution

    UP Transfer GmbH Potsdam

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The aim of the project is to develop monoclonal antibodies against special protein building blocks of SARS-CoV-2. On this basis, an analytical rapid test for the specific detection of SARS-CoV-2 in patient samples, such as B serum will be established. The planned test procedure can form the basis for further research into the virus and the course of the disease and could possibly also be used in diagnostic procedures. The project builds on the BMWi-funded project "Monoclonal antibodies for the detection of respiratory disease MERS-CoV for use in rapid tests" (16KN073822).